Logo image of IBIO

IBIO INC (IBIO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:IBIO - US4510337086 - Common Stock

1.17 USD
+0.06 (+5.41%)
Last: 11/25/2025, 8:00:02 PM
1.1213 USD
-0.05 (-4.16%)
After Hours: 11/25/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
IBIO revenue by date.IBIO revenue by date.

-100.00%
225K400K
77.78%
127.5K
-68.13%
170.003K
33.34%
255K
50.00%
255K255K63.24M
24,700.00%
169.07M
167.35%
EBITDA
YoY % growth
IBIO ebitda by date.IBIO ebitda by date.
-27.74M
-12.44%
-15.705M
43.39%
-17.827M
-13.51%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IBIO ebit by date.IBIO ebit by date.
-28.77M
-2.97%
-16.634M
42.18%
-18.602M
-11.83%
-30.6M
-64.50%
-36.21M
-18.33%
-36.029M
0.50%
-55.679M
-54.54%
-74.619M
-34.02%
-89.167M
-19.50%
-97.101M
-8.90%
Operating Margin
IBIO operating margin by date.IBIO operating margin by date.
N/A-7,392.89%-4,650.50%-24,000.00%-21,299.57%-14,129.20%-21,834.80%-29,262.40%-141.00%-57.43%
EPS
YoY % growth
IBIO eps by date.IBIO eps by date.
-11.27
-97.37%
N/A
32.94%
-1.92
74.60%
-0.41
78.88%
-0.24
39.62%
-0.35
-41.67%
-0.40
-16.18%
-0.53
-30.38%
-0.49
6.80%
-0.41
15.62%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27
EPS
Q2Q % growth
-0.10
79.28%
-0.09
81.79%
-0.09
80.74%
-0.10
7.27%
Revenue
Q2Q % growth
25.5K
-87.25%
25.5K25.5K
-87.25%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-6.736M
-52.43%
-6.858M
-40.56%
-7.479M
-43.88%
-9.18M
-64.66%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2026
Q2Q % growth
-0.11
76.09%
-0.10-0.01-5.21%
Q4 2025
Q2Q % growth
-0.49
45.92%
-0.37-0.12-31.61%
Q3 2025
Q2Q % growth
-0.49
30.99%
-0.33-0.16-50.12%
Q2 2025
Q2Q % growth
-0.48 -0.47-0.01-2.30%
Q1 2025
Q2Q % growth
-0.46 -0.490.036.05%
Q4 2024
Q2Q % growth
-0.91
-117.42%
-0.48-0.43-88.99%
Q3 2024
Q2Q % growth
-0.71
93.55%
%
Q4 2023
Q2Q % growth
5.20
365.31%
-8.3613.56162.17%
Q3 2023
Q2Q % growth
-11.00
-633.33%
-7.34-3.66-49.78%
Q2 2023
Q2Q % growth
-3.42
-173.60%
-2.03-1.39-68.49%
Q1 2023
Q2Q % growth
-2.05
-105.00%
-1.89-0.16-8.35%
Q4 2022
Q2Q % growth
-1.96
-3,820.00%
-2.170.219.57%
Q3 2022
Q2Q % growth
-1.50
-50.00%
-1.40-0.10-6.95%
Q2 2022
Q2Q % growth
-1.25
-25.00%
-1.02-0.23-22.55%
Q1 2022
Q2Q % growth
-1.00
20.00%
-1.280.2721.57%
Q4 2021
Q2Q % growth
-0.05
96.08%
%
Q3 2021
Q2Q % growth
-1.00 -1.280.2721.57%
Q2 2021
Q2Q % growth
-1.00
21.57%
-1.020.021.96%
Q1 2021
Q2Q % growth
-1.25 -2.040.7938.73%
IBIO Yearly EPS VS EstimatesIBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -100 -200 -300
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2026
Q2Q % growth
100K 25.5K74.5K292.16%
Q4 2025
Q2Q % growth
200K
14.29%
200K%
Q3 2025
Q2Q % growth
102K-102K-100.00%
Q1 2025
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth
204K-204K-100.00%
Q3 2023
Q2Q % growth

-100.00%
204K-204K-100.00%
Q2 2023
Q2Q % growth
510K-510K-100.00%
Q1 2023
Q2Q % growth

-100.00%
612K-612K-100.00%
Q4 2022
Q2Q % growth

-100.00%
102K-102K-100.00%
Q3 2022
Q2Q % growth
1.8M
133.77%
204K1.596M782.35%
Q2 2022
Q2Q % growth

-100.00%
255K-255K-100.00%
Q1 2022
Q2Q % growth
80K
-80.49%
510K-430K-84.31%
Q4 2021
Q2Q % growth
490K
-56.25%
%
Q3 2021
Q2Q % growth
770K
670.00%
816K-46K-5.64%
Q2 2021
Q2Q % growth
710K
129.03%
510K200K39.22%
Q1 2021
Q2Q % growth
410K
272.73%
410K%
Q4 2020
Q2Q % growth
1.12M
40.00%
102K1.018M998.04%
Q3 2020
Q2Q % growth
100K
-81.13%
%
Q2 2020
Q2Q % growth
310K
-52.31%
102K208K203.92%
Q1 2020
Q2Q % growth
110K
120.00%
%
IBIO Yearly Revenue VS EstimatesIBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS33.87% 48.75% 32.05% 51.52%
RevenueN/A N/A N/A N/A